argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
21 sep 2023 - 07:07
Statutory name
argenx SE
Title
argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada for Generalized Myasthenia Gravis
Related downloads
Date last update: 04 April 2026